2-naphthol has been researched along with transforming growth factor beta in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Alon, U; Antebi, YE; Friedman, N; Hart, Y; Mayo, AE | 1 |
| Pal, S; Sainis, KB; Shankar, BS | 1 |
| El-Maraghy, SA; Nassar, NN; Rizk, SM | 1 |
| Bogdanovich, S; Earley, JU; Gao, QQ; Gardner, BB; Hadhazy, M; Lamar, KM; McNally, EM; Miller, T; Molkentin, JD; Vo, AH; Wren, L | 1 |
| Agarwal, SK; Assassi, S; Pedroza, M; To, S; Tweardy, D; Wu, M | 1 |
| Jeong, MH; Jeong, SK; Jo, WS; Kang, YR; Kim, JS; Lee, CG; Oh, SJ | 1 |
6 other study(ies) available for 2-naphthol and transforming growth factor beta
| Article | Year |
|---|---|
Design principles of cell circuits with paradoxical components.
Topics: Cell Proliferation; Gene Expression; Homeostasis; Humans; Interleukin-2; Interleukins; Models, Biological; Naphthols; Signal Transduction; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Triazines | 2012 |
Cytokines from the tumor microenvironment modulate sirtinol cytotoxicity in A549 lung carcinoma cells.
Topics: Apoptosis; Benzamides; Cell Line, Tumor; Cell Survival; Cisplatin; Cytokines; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Insulin-Like Growth Factor I; Janus Kinases; Lung Neoplasms; Molecular Targeted Therapy; Naphthols; Paclitaxel; Phosphatidylinositol 3-Kinases; Receptor, IGF Type 1; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Sirtuin 1; TNF-Related Apoptosis-Inducing Ligand; Transforming Growth Factor beta; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Tyrphostins | 2013 |
A novel role for SIRT-1 in L-arginine protection against STZ induced myocardial fibrosis in rats.
Topics: Animals; Apoptosis; Arginine; Benzamides; Biomarkers; Blood Glucose; Cytoprotection; Diabetes Complications; Fasting; Fibrosis; Gene Expression Regulation, Enzymologic; Glycated Hemoglobin; Insulin; Interleukin-1beta; Male; Matrix Metalloproteinase 2; Myocardium; Naphthols; Rats; Rats, Wistar; Sirtuin 1; Streptozocin; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2014 |
Overexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβ.
Topics: Animals; Bone Morphogenetic Proteins; Disease Models, Animal; Gene Expression Regulation; Growth Differentiation Factors; Humans; Latent TGF-beta Binding Proteins; Mice; Mice, Inbred mdx; Mice, Transgenic; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Myostatin; Naphthols; Transforming Growth Factor beta; Triazines | 2016 |
Role of STAT3 in skin fibrosis and transforming growth factor beta signalling.
Topics: Animals; Female; Fibrosis; Humans; Mice; Mice, Inbred C57BL; Naphthols; Scleroderma, Systemic; Signal Transduction; Skin; Skin Diseases; STAT3 Transcription Factor; Sulfonamides; Transforming Growth Factor beta | 2018 |
The resveratrol analogue, HS‑1793, enhances the effects of radiation therapy through the induction of anti‑tumor immunity in mammary tumor growth.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemoradiotherapy; Concanavalin A; Female; Interleukin-10; Mammary Neoplasms, Experimental; Mice; Naphthols; Radiation-Sensitizing Agents; Resorcinols; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Treatment Outcome; Xenograft Model Antitumor Assays | 2020 |